| Name | Glisan Care Center |
|---|---|
| Location | 9750 Ne Glisan Street, Portland, Oregon |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 60.2% |
| Medicare ID (CCN) | 385136 |
| Legal Business Name | Care Center (glisan), Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1992791214 |
| Organization Name | CARE CENTER (GLISAN) INC |
| Doing Business As | GLISAN CARE CENTER |
| Address | 9750 Ne Glisan St, Portland, OR 97220 |
| Phone Number | 503-256-3920 |
News Archive
The Obama administration is poised to enter the "same medical minefield" that 15 years ago resulted in unsuccessful federal efforts to develop guidelines for physicians in identifying cost-efficient and effective treatments for common medical conditions, the New York Times reports.
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that one of seven genetic risk factors previously identified as increasing the probability of developing prostate cancer also increases the probability of developing colorectal cancer.
Scientists have identified the structure of a key component of the bacteria behind such diseases as whooping cough, peptic stomach ulcers and Legionnaires' disease.
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The Obama administration is poised to enter the "same medical minefield" that 15 years ago resulted in unsuccessful federal efforts to develop guidelines for physicians in identifying cost-efficient and effective treatments for common medical conditions, the New York Times reports.
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that one of seven genetic risk factors previously identified as increasing the probability of developing prostate cancer also increases the probability of developing colorectal cancer.
Scientists have identified the structure of a key component of the bacteria behind such diseases as whooping cough, peptic stomach ulcers and Legionnaires' disease.
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.71 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.98 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 45.31 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.44 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.55 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.87 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.92 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 16 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 6.74 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.11 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 85.78 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 73.89 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.21 | 82.93 |
News Archive
The Obama administration is poised to enter the "same medical minefield" that 15 years ago resulted in unsuccessful federal efforts to develop guidelines for physicians in identifying cost-efficient and effective treatments for common medical conditions, the New York Times reports.
A study led by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that one of seven genetic risk factors previously identified as increasing the probability of developing prostate cancer also increases the probability of developing colorectal cancer.
Scientists have identified the structure of a key component of the bacteria behind such diseases as whooping cough, peptic stomach ulcers and Legionnaires' disease.
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer in women with metastatic disease.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
› Verified 8 days ago
Avamere Crestview Of Portland Location: 6530 Sw 30th Avenue, Portland, Oregon 97239 Phone: (503) 244-7533 | |
Prestige Care And Rehabilitation - Menlo Park Location: 745 Ne 122nd Avenue, Portland, Oregon 97230 Phone: (503) 252-0241 | |
Porthaven Healthcare Center Location: 5330 Ne Prescott Street, Portland, Oregon 97218 Phone: (503) 288-6585 | |
Prestige Care And Rehabilitation Of Reedwood Location: 3540 Se Francis Street, Portland, Oregon 97202 Phone: (503) 232-5767 | |
West Hills Health & Rehabilitation Location: 5701 Sw Multnomah Blvd, Portland, Oregon 97219 Phone: (503) 244-1107 |